Conversion of Mouse Fibroblasts into Oligodendrocyte Progenitor-like Cells Through a Chemical Approach
Overview
Authors
Affiliations
Transplantation of oligodendrocyte progenitor cells (OPCs) is a promising way for treating demyelinating diseases. However, generation of scalable and autologous sources of OPCs has proven difficult. We previously established a chemical condition M9 that could specifically initiate neural program in mouse embryonic fibroblasts. Here we found that M9 could induce the formation of colonies that undergo mesenchymal-to-epithelial transition at the early stage of reprogramming. These colonies may represent unstable and neural lineage-restricted intermediates that have not established a neural stem cell identity. By modulating the culture signaling recapitulating the principle of OPC development, these intermediate cells could be reprogrammed towards OPC fate. The chemical-induced OPC-like cells (ciOPLCs) resemble primary neural stem cell-derived OPCs in terms of their morphology, gene expression, and the ability of self-renewal. Upon differentiation, ciOPLCs could produce functional oligodendrocytes and myelinate the neuron axons in vitro, validating their OPC identity molecularly and functionally. Therefore, our study provides a non-integrating approach to OPC reprogramming that may ultimately provide an avenue to patient-specific cell-based or in situ regenerative therapy.
Chemical transdifferentiation of somatic cells to neural cells: a systematic review.
Visintin P, Zampieri B, Griesi-Oliveira K Einstein (Sao Paulo). 2024; 22:eRW0423.
PMID: 39661857 PMC: 11634374. DOI: 10.31744/einstein_journal/2024RW0423.
Sharifi-Kelishadi M, Zare L, Fathollahi Y, Javan M J Mol Neurosci. 2024; 74(2):40.
PMID: 38594388 DOI: 10.1007/s12031-024-02206-6.
Glial-restricted progenitor cells: a cure for diseased brain?.
Rogujski P, Lukomska B, Janowski M, Stanaszek L Biol Res. 2024; 57(1):8.
PMID: 38475854 PMC: 10935984. DOI: 10.1186/s40659-024-00486-1.
Chen J, Huang L, Yang Y, Xu W, Qin Q, Qin R Brain Sci. 2023; 13(3).
PMID: 36979334 PMC: 10046178. DOI: 10.3390/brainsci13030524.
The Journey of iPSC-derived OPCs in Demyelinating Disorders: From Generation to Transplantation.
Lohrasbi F, Ghasemi-Kasman M, Soghli N, Ghazvini S, Vaziri Z, Abdi S Curr Neuropharmacol. 2023; 21(9):1980-1991.
PMID: 36825702 PMC: 10514531. DOI: 10.2174/1570159X21666230220150010.